NGL FINECHEM
Back to Cashflow Statement
|
NGL FINECHEM Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-1.08 Cr | ₹-1.08 Cr | ₹-1.08 Cr | ₹-1.08 Cr | ₹-1.08 Cr |
What is the latest Cash Flow from Financing Activities ratio of NGL FINECHEM ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-1.08 Cr |
| Mar2024 | ₹-1.08 Cr |
| Mar2023 | ₹-1.08 Cr |
| Mar2022 | ₹-1.08 Cr |
| Mar2021 | ₹-1.08 Cr |
How is Cash Flow from Financing Activities of NGL FINECHEM Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-1.08 Cr | Negative | |
| Mar2024 | ₹-1.08 Cr | Negative | |
| Mar2023 | ₹-1.08 Cr | Negative | |
| Mar2022 | ₹-1.08 Cr | Negative | |
| Mar2021 | ₹-1.08 Cr | - | |
Compare Cash Flow from Financing Activities of peers of NGL FINECHEM
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NGL FINECHEM | ₹1,899.4 Cr | 14.7% | 39.8% | 157.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹433,620.0 Cr | 1% | -0.9% | 6.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,087.0 Cr | 1.8% | -2.3% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹154,837.0 Cr | 3.7% | 6.5% | 44.9% | Stock Analytics | |
| CIPLA | ₹112,194.0 Cr | 0% | 4.7% | -8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,328.0 Cr | -0.2% | 0.7% | -3.4% | Stock Analytics | |
NGL FINECHEM Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NGL FINECHEM | 14.7% |
39.8% |
157.8% |
| SENSEX | 1.7% |
1.3% |
-7.3% |
You may also like the below Video Courses